Anti-Viral Photodynamic Inactivation of T4-like Bacteriophage as a Mammalian Virus Model in Blood

Int J Mol Sci. 2022 Sep 30;23(19):11548. doi: 10.3390/ijms231911548.

Abstract

The laboratorial available methods applied in plasma disinfection can induce damage in other blood components. Antimicrobial photodynamic therapy (aPDT) represents a promising approach and is approved for plasma and platelet disinfection using non-porphyrinic photosensitizers (PSs), such as methylene blue (MB). In this study, the photodynamic action of three cationic porphyrins (Tri-Py(+)-Me, Tetra-Py(+)-Me and Tetra-S-Py(+)-Me) towards viruses was evaluated under white light irradiation at an irradiance of 25 and 150 mW·cm-2, and the results were compared with the efficacy of the approved MB. None of the PSs caused hemolysis at the isotonic conditions, using a T4-like phage as a model of mammalian viruses. All porphyrins were more effective than MB in the photoinactivation of the T4-like phage in plasma. Moreover, the most efficient PS promoted a moderate inactivation rate of the T4-like phage in whole blood. Nevertheless, these porphyrins, such as MB, can be considered promising and safe PSs to photoinactivate viruses in blood plasma.

Keywords: antimicrobial photodynamic therapy; blood; methylene blue; photosensitizers; plasma; porphyrins; viral inactivation.

MeSH terms

  • Anti-Infective Agents*
  • Bacteriophages*
  • Methylene Blue / pharmacology
  • Photochemotherapy* / methods
  • Photosensitizing Agents / pharmacology
  • Porphyrins* / pharmacology

Substances

  • Anti-Infective Agents
  • Photosensitizing Agents
  • Porphyrins
  • Methylene Blue